Lyndon J. Kim

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text

Medicine, Immunology, Oncology +17

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases

Noelle L. Williams, Evan Wuthrick, Hyun Kim et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 116 citations

Medicine, Oncology, Radiation Oncology +17

NRG/RTOG 1122: A phase 2, double‐blinded, placebo‐controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

Eudocia Q. Lee, Peixin Zhang, Patrick Y. Wen et al. · Cancer · 2020 · 41 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.

Patrick Y. Wen, David A. Reardon, Surasak Phuphanich et al. · Journal of Clinical Oncology · 2014 · 40 citations

Medicine, Immunology, Oncology +17